Allogene Therapeutics Operating Margin Growth & History (ALLO)

Allogene Therapeutics's operating margin was −1,241,813.64% for fiscal 2024.

View full Allogene Therapeutics company overview

Allogene Therapeutics annual operating margin history

Allogene Therapeutics annual operating margin

Fiscal yearPeriod endedOperating marginChange (percentage points)
20242024-12-31−1,241,813.64%−896827.32 pp
20232023-12-31−344,986.32%−129899.14 pp
20222022-12-31−215,087.18%−214929.24 pp
20212021-12-31−157.94%—

Allogene Therapeutics operating margin trends

Between the periods ended 2021-12-31 and 2024-12-31, Allogene Therapeutics's operating margin decreased from −157.94% to −1,241,813.64%, a change of −1241655.70 percentage points. The latest reported quarter, Q2 2026, shows −1,011.21%.

About the metric

What operating margin means

Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.

Calculation and source

How operating margin is calculated

TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Allogene Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about ALLO yet. Start the conversation.

Write the first post